Nexalin Technology, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Nexalin Technology, Inc. (NXL) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.62 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- Nexalin Technology, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 4.11M shares, a 28.26% decline year-over-year.
- Nexalin Technology, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 4.11M shares, a 25.53% decline year-over-year.
- Nexalin Technology, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 5.90M shares, a 19.36% increase year-over-year.
- Nexalin Technology, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 5.73M shares, a 15.97% increase year-over-year.
- Nexalin Technology, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 4.44M shares, a 22.53% decline from fiscal 2024.
- Nexalin Technology, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 5.73M shares, a 15.97% increase from fiscal 2023.
- Nexalin Technology, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 4.94M shares, a 85.71% increase from fiscal 2022.
- Nexalin Technology, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 2.66M shares, a 12225.23% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 4.62M shares 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | 4.11M shares 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | 4.44M shares 10-K · filed 2026-03-25 | |||
| 2025-09-30 | 4.11M shares 10-Q · filed 2025-11-14 | 4.11M shares 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | 5.90M shares 10-Q · filed 2025-08-06 | 5.90M shares 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | 5.73M shares 10-Q · filed 2026-05-08 | |||
| 2024-12-31 | 5.73M shares 10-K · filed 2026-03-25 | |||
| 2024-09-30 | 5.53M shares 10-Q · filed 2025-11-14 | 5.53M shares 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | 4.94M shares 10-Q · filed 2025-08-06 | 4.94M shares 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | 4.94M shares 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | 4.94M shares 10-K/A · filed 2025-09-23 | |||
| 2023-09-30 | 2.66M shares 10-Q · filed 2024-11-08 | 2.66M shares 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | 2.66M shares 10-Q · filed 2024-08-08 | 2.66M shares 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | 2.66M shares 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | 2.66M shares 10-K · filed 2024-03-27 | |||
| 2022-09-30 | 2.50M shares 10-Q · filed 2023-11-13 | 2.50M shares 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | 21.60K shares 10-Q · filed 2023-08-10 | 21.60K shares 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | 21.60K shares 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | 21.60K shares 10-K · filed 2023-03-27 | |||
| 2021-09-30 | 40.80K shares 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |